Skip Nav Destination
Issues
1 August 2013
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0149-5992
EISSN 1935-5548
Introduction
Introduction to the 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Diabetes Care July 2013, Vol.36, S111-S112. doi:https://doi.org/10.2337/dcS13-2046
Diabetes Pathophysiology
Role of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
Diabetes Care July 2013, Vol.36, S113-S119. doi:https://doi.org/10.2337/dcS13-2008
Genetic Screening for the Risk of Type 2 Diabetes: Worthless or valuable?
Diabetes Care July 2013, Vol.36, S120-S126. doi:https://doi.org/10.2337/dcS13-2009
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
Diabetes Care July 2013, Vol.36, S127-S138. doi:https://doi.org/10.2337/dcS13-2011
Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
Diabetes Care July 2013, Vol.36, S139-S144. doi:https://doi.org/10.2337/dcS13-2035
GLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
Diabetes Care July 2013, Vol.36, S145-S148. doi:https://doi.org/10.2337/dcS13-2015
Diabetes Therapy
Is Physical Exercise a Core Therapeutical Element for Most Patients With Type 2 Diabetes?
Diabetes Care July 2013, Vol.36, S149-S154. doi:https://doi.org/10.2337/dcS13-2024
Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
Diabetes Care July 2013, Vol.36, S155-S161. doi:https://doi.org/10.2337/dcS13-2031
In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
Diabetes Care July 2013, Vol.36, S162-S174. doi:https://doi.org/10.2337/dcS13-2003
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
Diabetes Care July 2013, Vol.36, S175-S179. doi:https://doi.org/10.2337/dcS13-2037
Insulin Therapy
Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?
Diabetes Care July 2013, Vol.36, S198-S204. doi:https://doi.org/10.2337/dcS13-2019
Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
Diabetes Care July 2013, Vol.36, S205-S211. doi:https://doi.org/10.2337/dcS13-2026
Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
Diabetes Care July 2013, Vol.36, S212-S218. doi:https://doi.org/10.2337/dcS13-2007
Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
Diabetes Care July 2013, Vol.36, S219-S225. doi:https://doi.org/10.2337/dcS13-2027
Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
Diabetes Care July 2013, Vol.36, S226-S232. doi:https://doi.org/10.2337/dcS13-2036
Diabetes and Cancer
Epidemiology and Molecular Mechanisms Tying Obesity, Diabetes, and the Metabolic Syndrome With Cancer
Diabetes Care July 2013, Vol.36, S233-S239. doi:https://doi.org/10.2337/dcS13-2001
Insulin Therapy and Cancer
Diabetes Care July 2013, Vol.36, S240-S244. doi:https://doi.org/10.2337/dcS13-2002
Do GLP-1–Based Therapies Increase Cancer Risk?
Diabetes Care July 2013, Vol.36, S245-S252. doi:https://doi.org/10.2337/dcS13-2004
The Heart in Diabetes
Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations
Diabetes Care July 2013, Vol.36, S253-S258. doi:https://doi.org/10.2337/dcS13-2041
Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
Diabetes Care July 2013, Vol.36, S259-S263. doi:https://doi.org/10.2337/dcS13-2018
Obesity
Obesity Paradox Does Exist
Diabetes Care July 2013, Vol.36, S276-S281. doi:https://doi.org/10.2337/dcS13-2023
Defending the Con Side: Obesity Paradox Does Not Exist
Diabetes Care July 2013, Vol.36, S282-S286. doi:https://doi.org/10.2337/dcS13-2040
Mechanism of Metabolic Advantages After Bariatric Surgery: It’s all gastrointestinal factors versus it’s all food restriction
Diabetes Care July 2013, Vol.36, S287-S291. doi:https://doi.org/10.2337/dcS13-2032
Targets for Body Fat, Blood Pressure, Lipids, and Glucose-Lowering Interventions in Healthy Older People
Constantine Tsigos, MD, PHD; Rafael Bitzur, MD; Yosef Kleinman, MD; Hofit Cohen, MD; Avivit Cahn, MD; Gianmaria Brambilla, MD; Giuseppe Mancia, MD; Guido Grassi, MD
Diabetes Care July 2013, Vol.36, S292-S300. doi:https://doi.org/10.2337/dcS13-2021
Hypertension
Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension
Diabetes Care July 2013, Vol.36, S307-S311. doi:https://doi.org/10.2337/dcS13-2039
Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes
Gianfranco Parati, MD; Juan Eugenio Ochoa, MD; Paolo Salvi, MD; Carolina Lombardi, MD; Grzegorz Bilo, MD
Diabetes Care July 2013, Vol.36, S312-S324. doi:https://doi.org/10.2337/dcS13-2043
Intolerance to Statins: Mechanisms and Management
Diabetes Care July 2013, Vol.36, S325-S330. doi:https://doi.org/10.2337/dcS13-2038